|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative expenses | |||||
| Impairment of goodwill and intangible asset | |||||
| Impairment charges | |||||
| Research and development expenses | |||||
| Restructuring costs | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other non-operating income and expense: | |||||
| Interest expense, net | |||||
| Loss on write-off of deferred financing and extinguishment of convertible debt | |||||
| Other non-operating (income)/expense, net | |||||
| Total other non-operating (income) expense, net | |||||
| Income before income taxes | |||||
| (Benefit)/Provision for income taxes | |||||
| Net income/(loss) | |||||
| Weighted average shares, basic | |||||
| Weighted average shares, diluted | |||||
| Net income/(loss) per share: | |||||
| Basic | |||||
| Diluted | |||||
| Cash dividend declared per share | |||||
Loading...